EphA2 as a Diagnostic Imaging Target in Glioblastoma: A Positron Emission Tomography/Magnetic Resonance Imaging Study

EphA2 as a Diagnostic Imaging Target in Glioblastoma: A Positron Emission Tomography/Magnetic Resonance Imaging Study

Noninvasive imaging is a critical technology for diagnosis, classification, and subsequent treatment planning for patients with glioblastoma. It has been shown that the EphA2 receptor tyrosine kinase (RTK) is overexpressed in a number of tumors, including glioblastoma. Expression levels of Eph RTKs...

Full description

Bibliographic Details
Main Authors: Simon Puttick, Brett W. Stringer, Bryan W. Day, Zara C. Bruce, Kathleen S. Ensbey, Karine Mardon, Gary J. Cowin, Kristofer J. Thurecht, Andrew K. Whittaker, Michael Fay, Andrew W. Boyd, Stephen Rose
Format: Article
Language:English
Published: Hindawi - SAGE Publishing 2015-07-01
Series:Molecular Imaging
Online Access:https://doi.org/10.2310/7290.2015.00008

Internet

https://doi.org/10.2310/7290.2015.00008

Similar Items